> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Vote on Lumicell NDA
- URL: https://www.fdaweb.com/panel-to-vote-on-lumicell-nda/
- Published: 2024-01-19T12:00:00.000Z
- Updated: 2026-09-14T14:20:42.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156172

*Federal Register* notice: FDA is announcing a 3/5 Medical Imaging Drugs Advisory Committee meeting to review a Lumicell NDA for pegulicianine for injection. The optical imaging drug constituent of the company’s drug/device combination product has a proposed indication for use in patients with breast cancer to assist in detecting cancerous tissue within the lumpectomy cavity following removal of the primary specimen during lumpectomy surgery. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-01-19/pdf/2024-01016.pdf?ref=fdaweb.com).